Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer
Conditions
- Anal, Colon, and Rectal Cancers
- Colorectal Neoplasms
- Colon/Rectal Cancer
Interventions
- DRUG: Vandetanib
- DRUG: Capecitabine
- DRUG: Oxaliplatin
- DRUG: Bevacizumab
Sponsor
Branimir Sikic
Collaborators